Aethlon Medical amended executive agreements so qualifying change-in-control severance and health-care payments will be made as lump sums after a change in control where existing holders retain no more than 50% of voting power. For investors, benefit amounts and eligibility conditions remain unchanged while payment timing becomes defined.

Key Highlights

  • The amendments cover CEO and Chief Financial Officer James B. Frakes and Chief Medical Officer Steven P. LaRosa.
  • Qualifying lump-sum payments are due on the first regular Payroll date after the applicable release becomes effective.
  • Health-care continuation payments cannot later be reduced, forfeited or recouped because of new employer coverage or changed COBRA eligibility.

Executive Agreements Amended September 11

The amendments cover James B. Frakes and Steven P. LaRosa, M.D. The changes apply to Frakes, the chief executive officer and chief financial officer, and LaRosa, the chief medical officer. Frakes’ employment agreement dates to December 12, 2018, while LaRosa’s agreement dates to January 4, 2021; Frakes’ agreement was previously amended on November 7, 2023. The amendments do not change the amount or calculation of severance or health-care continuation payments, or the conditions that make either executive eligible for those benefits. Aethlon Medical (NASDAQ: AEMD) signed the report on September 15, 2026.

Payment Timing and Health-Care Protection

When the qualifying control transaction and termination or required resignation occur together, severance that would otherwise be paid in installments becomes payable in one amount. The payment is due on the first regular payroll date after the applicable release takes effect. Health-care continuation payments covering the applicable COBRA period also shift to one lump sum, and that amount remains unchanged if the executive later obtains group coverage through a new employer or stops qualifying for COBRA.